Skip to main content
. 2019 Nov 10;8(4):216. doi: 10.3390/antibiotics8040216

Table 2.

Risk factors of 30-day crude mortality in the overall cohort.

Variables Patient Number (%) Univariate Analysis Multivariate Analysis
Death n = 56 Survival n = 885 Odds Ratio (95% CI) p Value Odds Ratio (95%CI) p Value
Gender, male 37 (66.1) 359 (40.6) 2.85 (1.62–5.04) <0.001 NS NS
Pitt bacteremia score
 ≥4 at onset 30 (53.6) 117 (13.2) 7.57 (4.33–13.26) <0.001 2.59 (1.34–5.03) 0.005
 =0 ay day 3 11 (19.6) 690 (78.0) 0.07 (0.04–0.14) <0.001 0.21 (0.11–0.41) <0.001
Ultimately and rapidly fatal comorbidities (McCabe classification) 31 (55.4) 165 (18.6) 5.41 (3.11–9.41) <0.001 3.20 (1.62–6.33) 0.001
Comorbidities
 Malignancies 30 (53.6) 221 (25.0) 3.47 (2.01–5.99) <0.001 1.98 (1.02–3.86) 0.04
 Hypertension 18 (32.1) 444 (50.2) 0.47 (0.26–0.84) 0.009 NS NS
 Liver cirrhosis 18 (32.1) 108 (12.2) 3.41 (1.88–6.18) <0.001 2.15 (1.08–4.27) 0.03
Sources of bacteremia
 Pneumonia 22 (39.3) 69 (7.8) 7.65 (4.24–13.80) <0.001 3.19 (1.64–6.23) 0.001
 Urinary tract infections 10 (17.9) 466 (52.7) 0.20 (0.10–0.39) <0.001 0.32 (0.16–0.52) 0.001

NS = No significance (after processing the stepwise and backward multivariate regression).